Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DACH1 |
| Upstream (Parents) |
|---|
| (<<) C13orf23 → DACH1 |
| (<<) LY6G6D → DACH1 |
| (<<) BCL11A → DACH1 |
| (<<) ELF1 → DACH1 |
| (<<) TCF7 → DACH1 |
| Downstream (Children) |
|---|
| DACH1 → STEAP1 (>>) |
| DACH1 → HOXA6 (>>) |
| DACH1 → C1orf95 (>>) |
| DACH1 → GPR87 (>>) |
| DACH1 → WSCD1 (>>) |
| DACH1 → HOXA7 (>>) |
| DACH1 → CAB39L (>>) |
| DACH1 → IL1R2 (>>) |
| DACH1 → IL19 (>>) |
| DACH1 → HOXA2 (>>) |
| DACH1 → NELL2 (>>) |
| DACH1 → HOXA5 (>>) |
| DACH1 → GRIK3 (>>) |
| DACH1 → VAPB (>>) |
| DACH1 → ZMYM5 (>>) |
| DACH1 → SESN1 (>>) |
| DACH1 → KRT81 (>>) |
| DACH1 → RNASEH2B (>>) |
